COSM vs NUS
Cosmos Health Inc. and NU Skin Enterprises, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | COSM | NUS |
|---|---|---|
| Revenue | $65.3M | $1.5B |
| Net income | $-19.1M | $160.2M |
| Gross margin | 12.1% | 69.4% |
| Net margin | −29.3% | 10.8% |
| Return on equity | −89.1% | 22.0% |
| Diluted EPS | −$0.63 | $3.18 |
| Dividend / share | — | $0.35 |
| Payout ratio | — | 7.4% |
| Free cash flow | $-8.5M | $46.0M |
| Equity | $18.4M | $805.2M |
| Net debt / equity | 0.17× | −0.02× |
| Current ratio | 1.00× | 2.08× |
| Revenue CAGR 5y | 3.3% | −10.5% |
| Profit CAGR 5y | — | −3.5% |
NUS bills 22.8× the revenue of COSM, and COSM closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | COSM | NUS |
|---|---|---|
| FY2025 | $65.3M | $1.5B |
| FY2024 | $54.4M | $1.7B |
| FY2023 | $53.4M | $2.0B |
| FY2022 | $50.3M | $2.2B |
| FY2021 | $56.2M | $2.7B |
| FY2020 | $55.4M | $2.6B |
| FY2019 | $39.7M | $2.4B |
| FY2018 | $37.1M | $2.7B |
| FY2017 | $30.0M | $2.3B |
| FY2016 | $6.8M | $2.2B |
Net income by year
Bottom line
| Fiscal year | COSM | NUS |
|---|---|---|
| FY2025 | $-19.1M | $160.2M |
| FY2024 | $-16.2M | $-146.6M |
| FY2023 | $-18.5M | $8.6M |
| FY2022 | $-13.8M | $104.8M |
| FY2021 | $-8.0M | $147.3M |
| FY2020 | $820,786 | $191.4M |
| FY2019 | $-3.3M | $173.6M |
| FY2018 | $-9.1M | $121.9M |
| FY2017 | $-6.2M | $129.4M |
| FY2016 | $-601,002 | $143.1M |
Advertisement
AdSense · Rectangle 336×280